南方医科大学学报 ›› 2024, Vol. 44 ›› Issue (6): 1109-1116.doi: 10.12122/j.issn.1673-4254.2024.06.11

• • 上一篇    

澳洲茄碱通过调控Bcl-2/Bax/caspase-3信号通路促进非小细胞肺癌发生凋亡

陈桂玲1(), 廖晓凤1, 孙鹏涛1, 岑欢1, 舒盛春1, 李碧晶1, 黎金华1,2,3()   

  1. 1.广州中医药大学第二附属医院,广东 广州 510120
    2.广东省第二人民医院,广东 广州 510317
    3.南方医科大学生物医学工程学院,广东 广州 510515
  • 收稿日期:2024-02-05 出版日期:2024-06-20 发布日期:2024-07-01
  • 通讯作者: 黎金华 E-mail:guilingchen@gzucm.edu.cn;lijinhua0226@163.com
  • 作者简介:陈桂玲,硕士,实习研究员,E-mail: guilingchen@gzucm.edu.cn
  • 基金资助:
    国家自然科学基金青年项目(82104456);中国博士后基金资助项目(2020M672745);广州市科技计划项目(202102020205);广东省中医药局中医药科研项目(20244026)

Solasonine promotes apoptosis of non-small cell lung cancer cells by regulating the Bcl-2/Bax/caspase-3 pathway

Guiling CHEN1(), Xiaofeng LIAO1, Pengtao SUN1, Huan CEN1, Shengchun SHU1, Bijing LI1, Jinhua LI1,2,3()   

  1. 1.Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China
    2.Guangdong Second Provincial General Hospital, Guangzhou 510317, China
    3.School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China
  • Received:2024-02-05 Online:2024-06-20 Published:2024-07-01
  • Contact: Jinhua LI E-mail:guilingchen@gzucm.edu.cn;lijinhua0226@163.com
  • Supported by:
    Natural Science Foundation for the Youth (NSFY) of China(82104456)

摘要:

目的 探讨龙葵活性成分澳洲茄碱对非小细胞肺癌细胞PC9增殖、凋亡的影响。 方法 体外培养PC9细胞,设对照组(0 μmol/L)及澳洲茄碱不同剂量组(0、2、5、10、15、20、25 μmol/L),CCK-8试剂盒检测澳洲茄碱对PC9细胞的增殖抑制作用;TMRE检测线粒膜电位;caspase3/7活性试剂盒联合GreenNuc™ Caspase-3/Annexin V-mCherry染色检测caspase-3活性;Annexin V-FITC/PI双染法检测细胞凋亡率;给药处理或者使用PTEN抑制剂后,Western blot检测细胞中相关蛋白的表达量。 结果 与对照组相比,经澳洲茄碱干预24、48、72 h后,PC9细胞的活力均明显降低(P<0.05);经澳洲茄碱干预24 h后,细胞线粒体膜电位明显降低,而细胞凋亡比例明显升高(P<0.05);caspase-3/7活力、活细胞Caspase-3活性及cleaved caspase-3蛋白表达均显著升高(P<0.01);PI3K和Akt磷酸化水平降低(P<0.05);而PTEN、Bax蛋白表达上调(P<0.05);抗凋亡蛋白Bcl-2蛋白的表达下调(P<0.05)。 结论 澳洲茄碱可通过调控Bcl-2/Bax/caspase-3通路及其上游蛋白活性而抑制PC9细胞增殖,促进其凋亡。

关键词: 澳洲茄碱, 肺癌, Bcl-2/Bax/caspase-3通路, 同源性磷酸酶-张力蛋白, 细胞凋亡

Abstract:

Objective To investigate the effect of solasonine, an active component of Solanum nigrum, on proliferation and apoptosis of non-small cell lung cancer PC9 cells. Methods PC9 cells were treated with 2, 5, 10, 15, 20, or 25 μmol/L solasonine, and the changes in cell proliferation were examined using CCK-8 assay. Tetramethyl rhodamine ethyl ester (TMRE) was used to detect the changes in mitochondrial membrane potential, and caspase-3/7 detection kit and GreenNuc™ caspase-3/Annexin V-mCherry kit for live cell were used to analyze the changes in caspase-3 of the cells. Annexin V-FITC/PI double staining was employed to analyze the apoptosis rate of the cells. The effect of PTEN inhibitors on solasonine-induced cell apoptosis was examined by detecting apoptosis-related protein expressions using Western blotting. Results Solasonine treatment for 24, 48, and 72 h significantly lowered the viability of PC9 cells. The cells treated with solasonine for 24 h showed significantly decreased mitochondrial membrane potential and increased cell apoptosis with enhanced caspase-3/7 and caspase-3 activities and expression of cleaved caspase-3. Solasonine treatment significantly decreased phosphorylation levels of PI3K and Akt, increased the protein expressions of PTEN and Bax, and lowered the expression of Bcl-2 protein in the cells. Conclusion Solasonine inhibits proliferation and induces apoptosis of PC9 cells by regulating the Bcl-2/Bax/caspase-3 pathway and its upstream proteins.

Key words: solasonine, lung cancer, Bcl-2/Bax/caspase-3 signaling pathway, homologous phosphatase tensin protein, apoptosis